Related Experiment Video
Updated: Jul 25, 2025

06:12
Multimodal Analytical Platform on a Multiplexed Surface Plasmon Resonance Imaging Chip for the Analysis of Extracellular Vesicle Subsets
Published on: March 17, 2023
1.5K
MXenes-Au NPs modified electrochemical biosensor for multiple exosome surface proteins analysis.
Zhangmin Wang1, Ze Zhang1, Yingcong Zhang2
1Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, 201399, China.
Talanta
|June 23, 2023
Summary
This study presents a novel electrochemical biosensor for detecting cancer biomarkers like EGFR, CEA, and EpCAM in exosomes. The MXene-Au NP-modified sensor offers sensitive detection for early and accurate cancer diagnosis.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Diagnostics
Background:
- Exosome-carried proteins are promising non-invasive biomarkers for cancer.
- Early cancer detection and precise diagnosis are critical challenges in oncology.
- Distinguishing subtle protein differences in exosomes is key for accurate diagnostics.
Purpose of the Study:
- To develop an electrochemical biosensor for detecting exosomal proteins.
- To assess the differential expression of EGFR, CEA, and EpCAM proteins.
- To enable sensitive detection of tumor biomarkers from various cancer cell lines.
Main Methods:
- Modification of an electrochemical biosensor with MXenes and Gold Nanoparticles (Au NPs).
- Utilizing the biosensor to detect specific exosomal proteins (EGFR, CEA, EpCAM).
- Testing the sensor's efficacy with exosomes derived from multiple cancer cell lines (A549, MCF-7, PC-3, HeLa).
Main Results:
- The developed biosensor demonstrated sensitive detection of tumor biomarkers.
- The sensor successfully identified exosomal proteins from diverse cancer cell origins.
- The study confirmed the potential of the biosensor for differential protein expression analysis.
Conclusions:
- The MXene-Au NP-based electrochemical biosensor is effective for detecting exosomal cancer biomarkers.
- This technology holds significant promise for early and accurate cancer diagnosis.
- The biosensor's ability to differentiate protein expression is crucial for clinical applications.

